A detailed history of Strategic Investment Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Strategic Investment Advisors holds 86,221 shares of PFE stock, worth $2.46 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
86,221
Previous 85,489 0.86%
Holding current value
$2.46 Million
Previous $2.37 Million 1.69%
% of portfolio
0.29%
Previous 0.31%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $18,490 - $21,667
732 Added 0.86%
86,221 $2.41 Million
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $49,191 - $56,487
1,900 Added 2.27%
85,489 $2.37 Million
Q4 2023

Jan 10, 2024

SELL
$26.13 - $33.94 $134,961 - $175,300
-5,165 Reduced 5.82%
83,589 $2.41 Million
Q3 2023

Oct 24, 2023

SELL
$32.09 - $37.51 $94,344 - $110,279
-2,940 Reduced 3.21%
88,754 $2.94 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $87,518 - $101,257
-2,423 Reduced 2.57%
91,694 $3.36 Million
Q1 2023

Apr 27, 2023

BUY
$39.39 - $51.28 $901,203 - $1.17 Million
22,879 Added 32.12%
94,117 $3.84 Million
Q4 2022

Jan 19, 2023

BUY
$41.75 - $54.5 $130,343 - $170,149
3,122 Added 4.58%
71,238 $0
Q3 2022

Oct 27, 2022

BUY
$43.76 - $53.42 $151,978 - $185,527
3,473 Added 5.37%
68,116 $2.98 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $437,428 - $518,653
9,401 Added 17.02%
64,643 $3.39 Million
Q1 2022

Apr 28, 2022

BUY
$45.75 - $56.69 $57,828 - $71,656
1,264 Added 2.34%
55,242 $2.86 Million
Q4 2021

Jan 26, 2022

SELL
$41.32 - $61.25 $15,412 - $22,846
-373 Reduced 0.69%
53,978 $3.19 Million
Q3 2021

Oct 19, 2021

BUY
$39.25 - $50.42 $62,643 - $80,470
1,596 Added 3.03%
54,351 $2.34 Million
Q2 2021

Jul 22, 2021

BUY
$35.91 - $40.68 $9,228 - $10,454
257 Added 0.49%
52,755 $2.07 Million
Q1 2021

Apr 14, 2021

BUY
$33.49 - $37.77 $342,267 - $386,009
10,220 Added 24.17%
52,498 $1.9 Million
Q4 2020

Jan 13, 2021

BUY
$33.47 - $42.56 $716,927 - $911,635
21,420 Added 102.69%
42,278 $1.56 Million
Q3 2020

Oct 14, 2020

BUY
$31.75 - $37.25 $75,596 - $88,692
2,381 Added 12.89%
20,858 $763,000
Q2 2020

Aug 04, 2020

BUY
$30.12 - $36.54 $22,559 - $27,368
749 Added 4.22%
18,477 $604,000
Q1 2020

Apr 13, 2020

BUY
$27.03 - $38.62 $98,308 - $140,460
3,637 Added 25.81%
17,728 $579,000
Q4 2019

Jan 23, 2020

BUY
$32.92 - $37.36 $193,668 - $219,788
5,883 Added 71.67%
14,091 $552,000
Q3 2019

Oct 25, 2019

BUY
$32.49 - $42.13 $266,677 - $345,803
8,208 New
8,208 $295,000
Q2 2019

Jul 23, 2019

SELL
$36.98 - $41.52 $218,292 - $245,092
-5,903 Closed
0 $0
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $4,800 - $5,273
128 Added 2.22%
5,903 $251,000
Q4 2018

Feb 08, 2019

BUY
$38.47 - $43.86 $222,164 - $253,291
5,775 New
5,775 $252,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Strategic Investment Advisors Portfolio

Follow Strategic Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.